D. Colledge

发表

In vitro studies identify a low replication phenotype for hepatitis B virus genotype H generally associated with occult HBV and less severe liver disease.

Zhenghong Yuan, P. Revill, S. Locarnini, 2018, Virology.

In vitro replication phenotype of a novel (−1G) hepatitis B virus variant associated with HIV co‐infection

S. Lewin, C. Thio, P. Revill, 2012, Journal of medical virology.

Phenylpropenamide Derivatives AT-61 and AT-130 Inhibit Replication of Wild-Type and Lamivudine-Resistant Strains of Hepatitis B Virus In Vitro

W. Delaney, S. Locarnini, G. Painter, 2002, Antimicrobial Agents and Chemotherapy.

Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A.

R. Hammond, P. Revill, N. Warner, 2021, Journal of hepatology.

Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype

P. Revill, N. Warner, S. Locarnini, 2013, Hepatology International.

Toll‐IL1 receptor‐mediated innate immune responses vary across HBV genotype and predict treatment response to pegylated‐IFN in HBeAg‐positive CHB patients

P. Revill, S. Ahn, E. Gane, 2016, Journal of viral hepatitis.

Single-Molecule Sequencing Reveals Complex Genome Variation of Hepatitis B Virus during 15 Years of Chronic Infection following Liver Transplantation

N. Beerenwinkel, F. Luciani, P. Angus, 2016, Journal of Virology.

Title : Single-molecule sequencing reveals complex genomic variation of hepatitis 1 B virus during 15 years of chronic infection following liver transplantation . 2 Running title : Single-molecule analysis reveals complex HBV

N. Beerenwinkel, F. Luciani, B. Betz-Stablein, 2016 .

Downregulation of Interleukin-18-Mediated Cell Signaling and Interferon Gamma Expression by the Hepatitis B Virus e Antigen

S. Kent, M. Navis, P. Revill, 2014, Journal of Virology.

Antigenby the Hepatitis B Virus e Cell Signaling and Interferon Gamma Downregulation of Interleukin-18-Mediated

S. Kent, M. Navis, S. Locarnini, 2014 .

Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals

S. Lewin, C. Thio, G. Dore, 2007, AIDS.

Long-Term Therapy with the Guanine Nucleoside Analog Penciclovir Controls Chronic Duck Hepatitis B Virus Infection In Vivo

S. Locarnini, Yan Yan Wang, E. Lin, 1998, Antimicrobial Agents and Chemotherapy.

Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro

Rachel Wilson, P. Revill, S. Locarnini, 2009, Antiviral therapy.

Cross-Resistance Testing of Antihepadnaviral Compounds Using Novel Recombinant Baculoviruses Which Encode Drug-Resistant Strains of Hepatitis B Virus

M. Manns, C. Trautwein, H. Isom, 2001, Antimicrobial Agents and Chemotherapy.

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging.

S. Locarnini, J. Feld, D. Colledge, 2007, Antiviral research.

Drug-Resistant Strains of Hepatitis B Virus Recombinant Baculoviruses Which Encode Antihepadnaviral Compounds Using Novel Cross-Resistance Testing of

M. Manns, C. Trautwein, H. Isom, 2000 .

Stop codons in the hepatitis B surface proteins are enriched during antiviral therapy and are associated with host cell apoptosis.

N. Warner, S. Locarnini, S. Soppe, 2017, Virology.

Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV)

M. Wulfsohn, C. Gibbs, P. Angus, 2003 .

Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro

S. Locarnini, D. Colledge, T. Shaw, 1997, Hepatology.

Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.

Angeline Bartholomeusz, C. Gibbs, P. Angus, 2003, Gastroenterology.

In Vitro Antihepadnaviral Activities of Combinations of Penciclovir, Lamivudine, and Adefovir

S. Locarnini, G. Civitico, D. Colledge, 2000, Antimicrobial Agents and Chemotherapy.

Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine‐resistant HBV in vitro

H. Isom, W. Delaney, S. Locarnini, 2003, Hepatology.

The hepatitis B e antigen suppresses IL‐1β‐mediated NF‐κB activation in hepatocytes

P. Revill, N. Warner, D. Colledge, 2011, Journal of viral hepatitis.

and Tim and Adefovir Combinations of Penciclovir , Lamivudine , In Vitro Antihepadnaviral Activities of

S. Locarnini, G. Civitico, D. Colledge, 1999 .

Inhibition of Duck Hepatitis B Virus Replication by 9-(2-Phosphonylmethoxyethyl)adenine, an Acyclic Phosphonate Nucleoside Analogue

P. Angus, S. Locarnini, R. Smallwood, 1998, Antimicrobial Agents and Chemotherapy.

Lamivudine and penciclovir act synergistically as inhibitors of in vitro hepadnaviral replication penciclovir

D. Colledge, T. Shaw, S. Locamini, 1997 .

SeqHepB: a sequence analysis program and relational database system for chronic hepatitis B.

S. Locarnini, D. Colledge, L. Yuen, 2007, Antiviral research.

Synthesis and evaluation of 2-amino-9-(3-acyloxymethyl-4-alkoxycarbonyloxybut-1-yl)purines and 2-amino-9-(3-alkoxycarbonyloxymethyl-4-alkoxycarbonyloxybut-1- yl)purines as potential prodrugs of penciclovir.

K. H. Kim, D. Ryu, D. Colledge, 1999, Bioorganic & medicinal chemistry.

242 Molecular modelling and functional studies of adefovir resistant mutations in the hepatitis B virus polymerase selected during therapy

P. Angus, H. Tillmann, B. Tehan, 2003 .

In Vitro Studies Show that Sequence Variability Contributes to Marked Variation in Hepatitis B Virus Replication, Protein Expression, and Function Observed across Genotypes

P. Revill, N. Warner, S. Locarnini, 2016, Journal of Virology.

Targeting the hepatitis B virus precore antigen with a novel IgNAR single variable domain intrabody.

O. Dolezal, P. Revill, S. Locarnini, 2011, Virology.

Cellular response to conditional expression of the hepatitis B virus precore and core proteins in cultured hepatoma (Huh-7) cells.

S. Lemon, S. Locarnini, M. Beard, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

482 Molecular analysis of HBV polymerase mutations associated with dual adefovir and lamivudine resistance

P. Angus, N. Warner, M. Kuiper, 2006 .

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B

M. Buti, P. Marcellin, R. Hammond, 2016, Gut.

Analysis of Hepatitis B Virus Haplotype Diversity Detects Striking Sequence Conservation Across Genotypes and Chronic Disease Phase

P. Marcellin, H. Janssen, A. Gaggar, 2020, Hepatology.

Molecular characterization of hepatitis B virus (HBV) in African children living in Australia identifies genotypes and variants associated with poor clinical outcome.

P. Revill, S. Locarnini, W. Hardikar, 2018, The Journal of general virology.

Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus

C. Begley, M. Pellegrini, J. Silke, 2015, Proceedings of the National Academy of Sciences.

The hepatitis B e antigen suppresses IL-1 beta-mediated NF-kappa B activation in hepatocytes

Kui Li, P. Revill, N. Warner, 2011 .